Onset of action of house dust mite sublingual immunotherapy tablet (SLIT-T) using an environmental exposure chamber

被引：0
|
作者：
Horak, F. [1 ]
Maloney, J. [2 ]
Nelson, S. H. [3 ]
Bernstein, D., I [4 ]
Li, Z. [2 ]
Zieglmayer, P. [1 ]
Zieglmayer, R. [1 ]
Lemell, P. [1 ]
Nolte, H. [2 ]
机构：
[1] Vienna Challenge Chamber, Vienna, Austria
[2] Merck, Whitehouse Stn, NJ USA
[3] Natl Jewish Hlth, Denver, CO USA
[4] Bernstein Allergy Grp, Cincinnati, OH USA
来源：
ALLERGY | 2014年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1778
引用
收藏
页码：610 / 610
页数：1
相关论文
共 50 条
  • [41] Treatment with the SQ house dust mite sublingual immunotherapy tablet may be initiated year-round
    Nolte, Hendrik
    Bernstein, David I.
    Kleine-Tebbe, Joerg
    Fejerskov, Peter A.
    Li, Qing
    Lu, Susan
    Nelson, Harrold S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (05): : 1758 - +
  • [42] House dust mite sublingual allergen immunotherapy tablet is safe and well tolerated in Dutch daily practice
    Tempels-Pavlica, Z.
    Aarts, M. C.
    Welsing, P.
    Van Der Meer, A. N.
    Uss, E.
    van der Zwan, L. P.
    Knulst, A.
    ALLERGY, 2023, 78 : 71 - 71
  • [43] Impact of Adverse Event Solicitation on the Safety Profile of SQ House Dust Mite Sublingual Immunotherapy Tablet
    Nolte, Hendrik
    Bernstein, David I.
    Sussman, Gordon L.
    Fogh, Bodil Svanholm
    Lu, Susan
    Husoy, Bernt
    Nelson, Harold S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (06): : 2081 - +
  • [44] House dust mite immunotherapy in Germany: real-world adherence to a subcutaneous allergoid and a sublingual tablet
    Vogelberg C.
    Brüggenjürgen B.
    Richter H.
    Jutel M.
    Allergo Journal International, 2021, 30 (5) : 183 - 191
  • [45] Using Biomarkers to Predict Asthma Response to House Dust Mite Sublingual Immunotherapy
    不详
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (06) : 743 - 743
  • [46] SIMILAR EFFICACY AND SAFETY BETWEEN ADOLESCENTS AND ADULTS RECEIVING HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY TABLET
    Bernstein, D.
    Nelson, H.
    Sussman, G.
    Okubo, K.
    Maekawa, Y.
    Nolte, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S25 - S25
  • [47] ADVERSE EVENT PROFILE OF SQ HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY TABLET AFTER TREATMENT INTERRUPTION
    Tilles, S.
    Nelson, H.
    Prenner, B.
    Maloney, J.
    Smith, I. Mosbech
    Nolte, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S15 - S16
  • [48] DOSE RANGING OF SUBLINGUAL TABLETS OF HOUSE DUST MITE ALLERGEN EXTRACT: RESULTS OF AN ENVIRONMENTAL EXPOSURE CHAMBER RHINITIS STUDY
    Yang, W. H.
    Sussman, G. L.
    Roux, M.
    Viatte, A.
    Cadic, V.
    Zeldin, R. K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A136 - A136
  • [49] Early onset of action of a five-grass pollen 300 IR sublingual immunotherapy (SLIT) tablet evaluated in an allergen challenge chamber
    Horak, F.
    Zieglmayer, P.
    Zieglmayer, R.
    Lemell, P.
    Devillier, P.
    Melac, M.
    Galvain, S.
    Moingeon, P.
    Le Gall, M.
    ALLERGY, 2009, 64 : 150 - 150
  • [50] Consistent efficacy and safety of SQ grass, tree, ragweed and house dust mite sublingual immunotherapy (SLIT)-tablets
    Durham, S. R.
    Bernstein, D.
    Hulstrom, V.
    Maekawa, Y.
    Matsuoka, T.
    Nolte, J.
    Nolte, H.
    Andersen, P. S.
    ALLERGY, 2023, 78 : 228 - 228
12345